Carboplatin and Paclitaxel in Combination With Either Vorinostat or Placebo for First-Line Therapy of Advanced Non―Small-Cell Lung CancerRAMALINGAM, Suresh S; MAITLAND, Michael L; BELANI, Chandra P et al.Journal of clinical oncology. 2010, Vol 28, Num 1, pp 56-62, issn 0732-183X, 7 p.Article

Randomized phase II trial of three schedules of pemetrexed and gemcitabine as front-line therapy for advanced non-small-cell lung cancerMA, Cynthia X; NAIR, Suresh; JETT, James R et al.Journal of clinical oncology. 2005, Vol 23, Num 25, pp 5929-5937, issn 0732-183X, 9 p.Article

Randomized Phase II Trial of Erlotinib or Standard Chemotherapy in Patients With Advanced Non-Small-Cell Lung Cancer and a Performance Status of 2LILENBAUM, Rogerio; AXELROD, Rita; THOMAS, Sachdev et al.Journal of clinical oncology. 2008, Vol 26, Num 6, pp 863-869, issn 0732-183X, 7 p.Article

Placebo-Controlled Trial to Determine the Effectiveness of a Urea/Lactic Acid-Based Topical Keratolytic Agent for Prevention of Capecitabine-Induced Hand-Foot Syndrome: North Central Cancer Treatment Group Study N05C5WOLF, Sherry L; RUI QIN; LOPRINZI, Charles L et al.Journal of clinical oncology. 2010, Vol 28, Num 35, pp 5182-5187, issn 0732-183X, 6 p.Article

Cediranib in patients with malignant mesothelioma: A phase II trial of the University of Chicago Phase II ConsortiumCAMPBELL, Nicholas P; KUNNAVAKKAM, Rangesh; VOKES, Everett E et al.Lung cancer. 2012, Vol 78, Num 1, pp 76-80, issn 0169-5002, 5 p.Article

Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Risedronate for the Prevention of Bone Loss in Premenopausal Women Undergoing Chemotherapy for Primary Breast CancerHINES, Stephanie L; MINCEY, Betty Anne; SLOAN, Jeff A et al.Journal of clinical oncology. 2009, Vol 27, Num 7, pp 1047-1053, issn 0732-183X, 7 p.Article

Mortality associated with daily bolus 5-fluorouracil/leucovorin administered in combination with either irinotecan or oxaliplatin : results from intergroup trial N9741DELAUNOIT, Thierry; GOLDBERG, Richard M; GREEN, Erin et al.Cancer. 2004, Vol 101, Num 10, pp 2170-2176, issn 0008-543X, 7 p.Article

Phase II Study of the Oral MEK Inhibitor Selumetinib in Advanced Acute Myelogenous Leukemia: A University of Chicago Phase II Consortium TrialJAIN, Nitin; CURRAN, Emily; POIRE, Xavier et al.Clinical cancer research (Print). 2014, Vol 20, Num 2, pp 490-498, issn 1078-0432, 9 p.Article